Pharma BD Deal Intelligence
Teva Pharmaceutical Industries Ltd. / Cephalon Inc.
2011 · Acquisition/Merger · $6.8B · Complete
Announcement Sentiment
75
Strongly positive
Outcome Score
46
Mixed — partial payoff, real shortfalls.
Teva acquired Cephalon for $6.8B, a specialty pharmaceutical company.
Did it work? Outcome assessment
Teva / Cephalon: Partially Achieved (Score: 52/100)
Strategic verdict
Partially Achieved
Assessment window: 5yr post-close.
Key facts
- Announced May 02, 2011
- Closed Oct 14, 2011
- Deal value $6.8B
- Deal type Acquisition/Merger
- Therapeutic area Neurology
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals